BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27158209)

  • 1. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy.
    Duarte-Rojo A; Ruiz-Margáin A; Macias-Rodriguez RU; Cubero FJ; Estradas-Trujillo J; Muñoz-Fuentes RM; Torre A
    World J Gastroenterol; 2016 May; 22(17):4397-402. PubMed ID: 27158209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of astroglial S100beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy.
    Wiltfang J; Nolte W; Otto M; Wildberg J; Bahn E; Figulla HR; Pralle L; Hartmann H; Rüther E; Ramadori G
    Metab Brain Dis; 1999 Dec; 14(4):239-51. PubMed ID: 10850551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of astroglial S100-beta and neuron-specific enolase in hepatic encephalopathy patients.
    Saleh A; Kamel L; Ghali A; Ismail A; El Khayat H
    East Mediterr Health J; 2007; 13(5):1114-23. PubMed ID: 18290405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
    Yao B; Zhang LN; Ai YH; Liu ZY; Huang L
    Neurochem Res; 2014 Jul; 39(7):1263-9. PubMed ID: 24760429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G; Hilger N; Häussinger D
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.
    Iwasa M; Sugimoto R; Mifuji-Moroka R; Hara N; Yoshikawa K; Tanaka H; Eguchi A; Yamamoto N; Sugimoto K; Kobayashi Y; Hasegawa H; Takei Y
    Metab Brain Dis; 2016 Oct; 31(5):1151-6. PubMed ID: 27353278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy.
    Labenz C; Beul L; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Eur J Intern Med; 2019 Feb; 60():96-100. PubMed ID: 30131209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
    Varakanahalli S; Sharma BC; Srivastava S; Sachdeva S; Dahale AS
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis.
    Gairing SJ; Danneberg S; Kaps L; Nagel M; Schleicher EM; Quack C; Engel S; Bittner S; Galle PR; Schattenberg JM; Wörns MA; Luessi F; Marquardt JU; Labenz C
    JHEP Rep; 2023 Apr; 5(4):100671. PubMed ID: 36866390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
    Kircheis G; Wettstein M; Timmermann L; Schnitzler A; Häussinger D
    Hepatology; 2002 Feb; 35(2):357-66. PubMed ID: 11826409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
    Tsai CF; Chu CJ; Huang YH; Wang YP; Liu PY; Lin HC; Lee FY; Lu CL
    PLoS One; 2015; 10(6):e0128437. PubMed ID: 26039496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolic profiling by
    McPhail MJ; Montagnese S; Villanova M; El Hadi H; Amodio P; Crossey MM; Williams R; Cox IJ; Taylor-Robinson SD
    Metab Brain Dis; 2017 Apr; 32(2):331-341. PubMed ID: 27638475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
    Tan L; Meng Y; Zeng T; Wang Q; Long T; Wu S; Guan X; Fu H; Zheng W; Tian Y; Chen J; Yu J; Wu Y; Li H; Cao L
    Br J Biomed Sci; 2019 Jan; 76(1):24-28. PubMed ID: 30392460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.
    Kurniawan J; Ranty SS; Sulaiman AS; Gani RA
    Acta Med Indones; 2023 Jul; 55(3):296-306. PubMed ID: 37915156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.